Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice

Melissa A Birkett Greene, Nina M. Shinday, Eileen J. Kessler, Jerrold S. Meyer, Sarah Ritchie, James K. Rowlett

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Selective serotonin re-uptake inhibitors (SSRIs), which are used commonly to treat anxiety disorders, have characteristic anxiogenic effects following acute administration. Treatment with anxiolytic benzodiazepines (BZs) may reduce these effects, although little is known about potential drug interactions. Our study evaluated acute anxiogenic-like effects of SSRIs, alone and combined with a BZ. Adult male BALB/c mice received fluoxetine (3.0-30.0 mg/kg, i.p.) or citalopram (3.0-30.0 mg/kg, i.p.) alone or in combination with diazepam (0.3-10.0 mg/kg, i.p.), after which they were evaluated with the light/dark and open-field tests for anxiogenesis/anxiolysis. In addition, release of the stress hormone corticosterone was assessed following combined SSRI/BZ administration. In the light/dark and open-field tests, acute SSRIs produced a behavioral profile consistent with anxiogenesis, while diazepam produced an anxiolytic-like profile. Pre-treatment with diazepam (0.3-10 mg/kg) reversed the effects of an anxiogenic-like dose of an SSRI (18 mg/kg fluoxetine, 30 mg/kg citalopram) in both light/dark and open-field tests. Diazepam, fluoxetine or citalopram, and their combination all significantly increased plasma corticosterone levels to the same degree. These findings suggest that a BZ-type drug can attenuate acute anxiogenic-like effects of an SSRI via a mechanism independent of corticosterone regulation.

Original languageEnglish (US)
Pages (from-to)544-551
Number of pages8
JournalPharmacology Biochemistry and Behavior
Volume98
Issue number4
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Serotonin Uptake Inhibitors
Diazepam
Benzodiazepines
Serotonin
Citalopram
Fluoxetine
Corticosterone
Anti-Anxiety Agents
Light
Drug interactions
Anxiety Disorders
Drug Interactions
Hormones
Plasmas
Pharmaceutical Preparations

Keywords

  • Anxiety
  • Benzodiazepine
  • Corticosterone
  • Light/dark
  • Mouse
  • Open field
  • SSRI

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Pharmacology
  • Toxicology
  • Behavioral Neuroscience
  • Biological Psychiatry

Cite this

Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. / Birkett Greene, Melissa A; Shinday, Nina M.; Kessler, Eileen J.; Meyer, Jerrold S.; Ritchie, Sarah; Rowlett, James K.

In: Pharmacology Biochemistry and Behavior, Vol. 98, No. 4, 06.2011, p. 544-551.

Research output: Contribution to journalArticle

Birkett Greene, Melissa A ; Shinday, Nina M. ; Kessler, Eileen J. ; Meyer, Jerrold S. ; Ritchie, Sarah ; Rowlett, James K. / Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. In: Pharmacology Biochemistry and Behavior. 2011 ; Vol. 98, No. 4. pp. 544-551.
@article{1278e4faa15e46cf9f4b3baf4bebaabd,
title = "Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice",
abstract = "Selective serotonin re-uptake inhibitors (SSRIs), which are used commonly to treat anxiety disorders, have characteristic anxiogenic effects following acute administration. Treatment with anxiolytic benzodiazepines (BZs) may reduce these effects, although little is known about potential drug interactions. Our study evaluated acute anxiogenic-like effects of SSRIs, alone and combined with a BZ. Adult male BALB/c mice received fluoxetine (3.0-30.0 mg/kg, i.p.) or citalopram (3.0-30.0 mg/kg, i.p.) alone or in combination with diazepam (0.3-10.0 mg/kg, i.p.), after which they were evaluated with the light/dark and open-field tests for anxiogenesis/anxiolysis. In addition, release of the stress hormone corticosterone was assessed following combined SSRI/BZ administration. In the light/dark and open-field tests, acute SSRIs produced a behavioral profile consistent with anxiogenesis, while diazepam produced an anxiolytic-like profile. Pre-treatment with diazepam (0.3-10 mg/kg) reversed the effects of an anxiogenic-like dose of an SSRI (18 mg/kg fluoxetine, 30 mg/kg citalopram) in both light/dark and open-field tests. Diazepam, fluoxetine or citalopram, and their combination all significantly increased plasma corticosterone levels to the same degree. These findings suggest that a BZ-type drug can attenuate acute anxiogenic-like effects of an SSRI via a mechanism independent of corticosterone regulation.",
keywords = "Anxiety, Benzodiazepine, Corticosterone, Light/dark, Mouse, Open field, SSRI",
author = "{Birkett Greene}, {Melissa A} and Shinday, {Nina M.} and Kessler, {Eileen J.} and Meyer, {Jerrold S.} and Sarah Ritchie and Rowlett, {James K.}",
year = "2011",
month = "6",
doi = "10.1016/j.pbb.2011.03.006",
language = "English (US)",
volume = "98",
pages = "544--551",
journal = "Pharmacology, Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice

AU - Birkett Greene, Melissa A

AU - Shinday, Nina M.

AU - Kessler, Eileen J.

AU - Meyer, Jerrold S.

AU - Ritchie, Sarah

AU - Rowlett, James K.

PY - 2011/6

Y1 - 2011/6

N2 - Selective serotonin re-uptake inhibitors (SSRIs), which are used commonly to treat anxiety disorders, have characteristic anxiogenic effects following acute administration. Treatment with anxiolytic benzodiazepines (BZs) may reduce these effects, although little is known about potential drug interactions. Our study evaluated acute anxiogenic-like effects of SSRIs, alone and combined with a BZ. Adult male BALB/c mice received fluoxetine (3.0-30.0 mg/kg, i.p.) or citalopram (3.0-30.0 mg/kg, i.p.) alone or in combination with diazepam (0.3-10.0 mg/kg, i.p.), after which they were evaluated with the light/dark and open-field tests for anxiogenesis/anxiolysis. In addition, release of the stress hormone corticosterone was assessed following combined SSRI/BZ administration. In the light/dark and open-field tests, acute SSRIs produced a behavioral profile consistent with anxiogenesis, while diazepam produced an anxiolytic-like profile. Pre-treatment with diazepam (0.3-10 mg/kg) reversed the effects of an anxiogenic-like dose of an SSRI (18 mg/kg fluoxetine, 30 mg/kg citalopram) in both light/dark and open-field tests. Diazepam, fluoxetine or citalopram, and their combination all significantly increased plasma corticosterone levels to the same degree. These findings suggest that a BZ-type drug can attenuate acute anxiogenic-like effects of an SSRI via a mechanism independent of corticosterone regulation.

AB - Selective serotonin re-uptake inhibitors (SSRIs), which are used commonly to treat anxiety disorders, have characteristic anxiogenic effects following acute administration. Treatment with anxiolytic benzodiazepines (BZs) may reduce these effects, although little is known about potential drug interactions. Our study evaluated acute anxiogenic-like effects of SSRIs, alone and combined with a BZ. Adult male BALB/c mice received fluoxetine (3.0-30.0 mg/kg, i.p.) or citalopram (3.0-30.0 mg/kg, i.p.) alone or in combination with diazepam (0.3-10.0 mg/kg, i.p.), after which they were evaluated with the light/dark and open-field tests for anxiogenesis/anxiolysis. In addition, release of the stress hormone corticosterone was assessed following combined SSRI/BZ administration. In the light/dark and open-field tests, acute SSRIs produced a behavioral profile consistent with anxiogenesis, while diazepam produced an anxiolytic-like profile. Pre-treatment with diazepam (0.3-10 mg/kg) reversed the effects of an anxiogenic-like dose of an SSRI (18 mg/kg fluoxetine, 30 mg/kg citalopram) in both light/dark and open-field tests. Diazepam, fluoxetine or citalopram, and their combination all significantly increased plasma corticosterone levels to the same degree. These findings suggest that a BZ-type drug can attenuate acute anxiogenic-like effects of an SSRI via a mechanism independent of corticosterone regulation.

KW - Anxiety

KW - Benzodiazepine

KW - Corticosterone

KW - Light/dark

KW - Mouse

KW - Open field

KW - SSRI

UR - http://www.scopus.com/inward/record.url?scp=79953097720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953097720&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2011.03.006

DO - 10.1016/j.pbb.2011.03.006

M3 - Article

C2 - 21397628

AN - SCOPUS:79953097720

VL - 98

SP - 544

EP - 551

JO - Pharmacology, Biochemistry and Behavior

JF - Pharmacology, Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -